For Diabetic Macular Edema, Brolucizumab Shows “Robust” Visual, Structural Gains
The intravitreal injection improves acuity and reduces retinal fluid in a 12-week therapy regimen for patients with diabetic macular edema, researchers report.
Macular Diseases
Intense Anti-VEGF Therapy May Increase Mortality Risk in Patients With DME
Patients who receive more frequent anti-VEGF injections for diabetic macular edema have a marginally higher death risk, research shows.
For Patients With Diabetes, Dietary Changes May Preserve Vision
Is it an ophthalmologist’s job to advise patients with diabetes on lifestyle choices, such as diet? Ophthalmologists Kristen Nwanyanwu, MD, Aleksandra Rachitskaya, MD, and Abdhish Bhavsar, MD, say it is, and suggest that saving vision may require putting patients in touch with a nutritionist.
Pandemic Measures Reduced Diabetic Eye Disease Monitoring, Treatments
Patients with diabetes underwent fewer injections and experienced worse vision loss than others, a report shows.
How Artificial Intelligence Is Primed to Change Ophthalmology
Innovators and educators including Michael D. Abràmoff, MD, T.Y. Alvin Liu, MD, Aaron Lee, MD, and Aazim A. Siddiqui, MD, speculate about how deep learning technologies are primed to expand ophthalmology’s capabilities.
- Loading...
Loading...
Next post in News
Loading... 
Loading...